We use cookies to improve your experience on this website. Read More Allow Cookies

Lower Price of Medicines may Save Irish Patients up to €500 Per Year

The Irish Pharmaceutical Healthcare Association (IPHA) announced that with effect from today, the 1st February 2010, the cost of long established medicines would be reduced by 40%.

IPHA

The Irish Pharmaceutical Healthcare Association (IPHA) announced that with effect from today, the 1st February 2010, the cost of long established medicines would be reduced by 40%.

IPHA, the representative body for the international research-based pharmaceutical industry in Ireland, has set up a special website on which patients can check to see if their medicines are listed, and the price reduction. The website – www.checkthelist.ie  - carries a detailed list of all the medicines and their new, lower prices. A lo-call number – (1890) 876 700 – has also been set up. checkthelist.ie includes some of the most commonly prescribed medicines in the country.

Commenting on the initiative, Brian Murphy, IPHA’s Director of Commercial Affairs, said:

We would urge patients to check the website as those who have to pay for their medicines could save €3 - €4 on every €10 they spend. That’s a potential saving of up to €500 per year,” said Mr Murphy.

The reduction in cost of nearly 300 named, familiar branded medicines is the result of an initiative by the industry to reduce costs for the State by €94m over the next 12 months.

“We were approached by the Minister for Health and Children with a request to create immediate savings on the State bill for medicines. Recognising the difficult position of the Irish economy and the tough decisions facing the Irish Government our member companies were willing to play their part in helping to reduce costs and prices. This initiative will significantly reduce costs for the State, and it will also reduce prices that patients pay directly for some of their medicines.“

IPHA said that its members will also pay an increased rebate to the HSE in respect of the manufacturer’s price of all other medicines dispensed under all of the community drug schemes.

IPHA said that its member companies look forward to continuing to work with the Department of Health and Children and the HSE in a positive manner and to finding solutions of benefit to both sides and most importantly of all to Irish patients. The constructive relationship has been a key factor in the industry’s willingness to locate so much foreign direct investment in this country - €7 billion alone in the last nine years.

Further Information:
www.checkthelist.ie

IPHA
IPHA is the representative body for the international research-based pharmaceutical industry in Ireland. Its members include both manufacturers of prescription medicines and non-prescription or consumer health care medicines.

Media queries:
Contact Jemma Hogan (085) 7229024 / (01) 668 0280

 

Published: 1st February 2010.


« Return to the News section